- 基本信息
导师姓名:
|
赵晋华
|
学科代码:
|
100207
|
|
性别:
|
女
|
学科名称:
|
影像医学与核医学
|
培养单位:
|
附属第一人民医院
|
三级学科
|
|
导师类型:
|
博士生导师
|
专业领域名称:
|
核医学 专业学位
|
联系方式:
|
13311985588,021-37798360
邮箱:zhaojinhua1963@126.com
|
专业领域代码:
|
105125
|
邮编:
|
200080
|
邮箱地址:
|
zjh1963@gmail.com
|
- 研究方向 (点击浏览详细信息)
- 社会任职
|
中华医学会核医学分会第8-10届委员会委员,实验学组副组长,淋巴瘤PET/CT工作委员会主任委员
|
上海核学会副理事长,核医学与分子影像专业委员会主任委员
|
中国影像技术研究会常务理事
|
《中华核医学与分子影像杂志》常务编委
|
上海医学会核医学专业委员会第7-8届委员会副主任委员
|
《国际放射医学核医学杂志》编委
|
中国医师协会核医学医师分会委员,继续教育委员工作委员会副主任委员
|
《肿瘤影像学》常务编委
|
中国核学会核医学分会副理事长
|
《中国医学影像学》杂志常务编委
|
- 科研项目
SHDC2020CR2057B | 99mTc/188Re标记纳米抗体用于HER2阳性乳腺癌诊疗一体化的临床研究 | 上海申康医院发展中心 |
2020-10~2022-09
|
240万元
| 课题负责人 |
CTCCR-2019B01 | 68Ga定点标记纳米抗体PET/CT检测非小细胞肺癌PD-L1表达的临床研究 | 上海市第一人民医院 |
2020-01~2022-12
|
60万元
| 课题负责人 |
81971647 | 68Ga定点标记纳米抗体检测非小细胞肺癌PD-L1表达及监测免疫治疗疗效的分子影像学研究 | 国家自然科学基金面上项目 |
2020-01~2022-12
|
55万元
| 课题负责人 |
无 | 临床核医学人才需求及人才培养现状调研 | 上海市教育委员会 |
2019-01~2019-12
|
10万元
| 课题负责人 |
17411953200 | 弥漫大B细胞性淋巴瘤PET/CT代谢放射组学的工具研发及多中心应用研究 | 上海市科学技术委员会“科技创新行动计划”临床医学领域项目 |
2017-10~2020-09
|
50万元
| 课题负责人 |
81671712 | 基于BmK CT 的新型纳米探针构建及其对脑胶质瘤的分子影像诊断与靶向治疗研究 | 国家自然科学基金面上项目 |
2017-01~2020-12
|
58万元
| 课题负责人 |
16CR3052A | 99mTc标记PD-L1抗体片段在非小细胞肺癌诊断中的临床研究 | 申康医院发展中心促进市级医院临床技能与临床创新三年行动计划 |
2016-12~2019-06
|
50万元
| 课题负责人 |
SHDC22015032 | 18F-FDG PET/CT显像指导I/II期霍奇金淋巴瘤早期疗效评估及治疗方案的应用研究 | 申康医院发展中心临床辅助科室能力建设项目 |
2016-01~2018-12
|
15万元
| 课题负责人 |
812111366 | 神经系统肿瘤和退行性疾病的放射性核素显像及靶向治疗进展 | 国家自然科学基金国际(地区)合作交流项目 |
2013-01~2013-12
|
6万元
| 课题负责人 |
81171368 | TfR抗体介导I-131标记BmK CT靶向显示和治疗脑胶质瘤的作用及作用机制研究 | 国家自然科学基金面上项目 |
2012-01~2015-12
|
57万元
| 课题负责人 |
2011PD12 | TfR单克隆抗体介导I-131标记BmK CT靶向显示和治疗脑胶质瘤的作用研究 | 市一医院与松江区合作“医学攀登项目” |
2011-01~2012-12
|
12万元
| 课题负责人 |
07SP07004 | 脑胶质瘤分子影像学诊断及双效靶向性治疗研究 | 上海市科委国际科技合作基金项目 |
2008-01~2009-09
|
25万元
| 课题负责人 |
30770600 | I-131标记的Chlorotoxin类似物作用于脑胶质瘤后分子生物学及分子影像学改变 | 国家自然基金委,面上项目 |
2008-01~2008-12
|
12万元
| 课题负责人 |
- 学术论文
Na Sun, Wenli Qiao, Yan Xing, Taisong Wang, Jiqin Yang,
|
Prognostic value of 18F-FDG PET/CT in T-Lymphoblastic lymphoma before and after hematopoietic stem cell transplantation
|
Clin Transl Oncol
|
2021
|
23(8):1571-1576
|
Junxiu Zhang, Jingyi Zhu, Lingzhou Zhao, Ke Mao, Qing Gu, Dongli Li,, Xingwei Wu
|
RGD-modified multifunctional nanoparticles encapsulating salvianolic acid A for targeted treatment of choroidal neovascularization
|
J Nanobiotechnology
|
2021
|
19(1):196
|
李思进,
|
淋巴瘤18F-FDG PET/CT及PET/MR显像临床应用指南
|
中华核医学与分子影像杂志
|
2021
|
41(3):161-169
|
Changcun Liu, Tiantian Wang, Lingzhou Zhao, Wenli Qiao, Meilin Zhu, Jiqin Yang,
|
Biological evaluation of [99mTc]Tc-labeled Buthus martensii Karsch Chlorotoxin peptide for glioma imaging
|
J Radioanal Nucl Chem
|
2020
|
326:193-199
|
Jingyi Zhu, Lingzhou Zhao, Pingping Zhao, Junxing Yang, Jianhui Shi,
|
Charge-conversional polyethylenimine-entrapped gold nanoparticles with 131I-labeling for enhanced dual mode SPECT/CT imaging and radiotherapy of tumors
|
Biomater Sci
|
2020
|
8(14):3956-3965
|
Lingzhou Zhao,Jingyi Zhu,Tiantian Wang,Changcun Liu,Ningning Song,Shan Wu,Wenli Qiao,Jiqin Yang,Meilin Zhu,
|
A novel Buthus martensii Karsch chlorotoxin derivative for glioma SPECT imaging
|
New J. Chem
|
2020
|
44, 14947-14952
|
Ningning Song, Lingzhou Zhao, Xiaoying Xu, Meilin Zhu, Changcun Liu, Na Sun, Jiqin Yang, Xiangyang Shi,
|
LyP-1-Modified Multifunctional Dendrimers for Targeted Antitumor and Antimetastasis Therapy
|
ACS Appl Mater Interfaces
|
2020
|
12(11):12395-406
|
Lingzhou Zhao, Jingyi Zhu, Jiali Gong, Ningning Song, Shan Wu, Wenli Qiao, Jiqin Yang, Meilin Zhu,
|
Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery
|
J Nanobiotechnol
|
2020
|
18:143
|
Na Sun, Lingzhou Zhao, Jingyi Zhu, Yujie Li, Ningning Song, Yan Xing, Wenli Qiao, He Huang,
|
131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy
|
Int J Nanomedicine
|
2019
|
14:4367-4381
|
Ningning Song, Lingzhou Zhao, Meilin Zhu,
|
99mTc-Labeled LyP-1 for SPECT Imaging of Triple Negative Breast Cancer
|
Contrast Media Mol Imaging
|
2019
|
9502712
|
Yujie Li, Lingzhou Zhao, Xiaoying Xu, Na Sun, Wenli Qiao, Yan Xing, Mingwu Shen, Meilin Zhu, Xiangyang Shi,
|
Design of 99mTc-Labeled Low Generation Dendrimer-Entrapped Gold Nanoparticles for Targeted Single Photon Emission Computed Tomography/Computed Tomography Imaging of Gliomas
|
J Biomed Nanotechnol
|
2019
|
15(6):1201-1212
|
Wei Zhu, Lingzhou Zhao, Yu Fan,, Xiangyang Shi, Mingwu Shen
|
131I-Labeled Multifunctional Polyphosphazene Nanospheres for SPECT Imaging-Guided Radiotherapy of Tumors
|
Adv Healthc Mater
|
2019
|
8(23):e1901299
|
Yan Xing, Gitasha Chand, Changchun Liu, Gary J. R. Cook, Jim O’Doherty, Lingzhou Zhao, Nicholas C. L. Wong, Levente K. Meszaros, Hong Hoi Ting,
|
Early phase I study of a 99mTc labeled anti-PD-L1 single domain antibody in SPECT/CT assessment of programmed death ligand-1 expression in non-small cell lung cancer
|
J Nucl Med
|
2019
|
60(9):1213-1220
|
Lingzhou Zhao, Yujie Li, Jingyi Zhu, Na Sun, Ningning Song, Yan Xing, He Huang,
|
Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT/CT imaging and radionuclide therapy
|
J Nanobiotechnology
|
2019
|
17(1):30
|
Jingyi Zhu, Lingzhou Zhao, Junxing Yang, Liang Chen, Jianhui Shi,, Xiangyang Shi
|
99mTc-Labeled Polyethylenimine-Entrapped Gold Nanoparticles with pH-Responsive Charge Conversion Property for Enhanced Dual Mode SPECT/CT Imaging of Cancer Cells
|
Langmuir
|
2019
|
35(41):13405-13412
|
Ningning Song, Lingzhou Zhao, Meilin Zhu,
|
Recent progress in LyP-1-based strategies for targeted imaging and therapy
|
Drug Deliv
|
2019
|
26(1):363-375
|
Lingzhou Zhao, Shihui Wen, Meilin Zhu, Du Li, Yan Xing, Mingwu Shen, Xiangyang Shi,
|
99mTc-labelled multifunctional polyethylenimine-entrapped gold nanoparticles for dual mode SPECT and CT imaging
|
Artif Cells Nanomed Biotechnol
|
2018
|
46(sup1):488-498
|
Yan Xing, Jingyi Zhu, Lingzhou Zhao, Zhijuan Xiong, Yujie Li, San Wu, Gitasha Chand, Xiangyang Shi,
|
SPECT/CT imaging of chemotherapy-induced tumor apoptosis using 99mTc-labeled dendrimerentrapped gold nanoparticles
|
Drug Deliv
|
2018
|
25(1): 1384-1393
|
Taisong Wang, Yan Xing, Wen Qiao,
|
Recurrent Leiomyosarcoma of External Oblique Muscle Detected on 99mTc-MDP SPECT/CT
|
Clin Nucl Med
|
2017
|
42(10):782-783.
|
Ying Zhuang, Lingzhou Zhao, Linfeng Zheng, Yong Hu, Ling Ding, Xin Li, Changcun Liu,, Xiangyang Shi, Rui Guo
|
Laponite-polyethylenimine based theranostic nanoplatform for tumor-targeting CT imaging and chemotherapy
|
ACS Biomater Sci Eng
|
2017
|
3:431-442
|
Benqing Zhou,Lingzhou Zhao,Mingwu Shen,,Xiangyang Shi
|
A multifunctional polyethylenimine-based nanoplatform for targeted anticancer drug delivery to tumors in vivo
|
Journal of Materials Chemistry B
|
2017
|
5:1542-1550
|
Wenli Qiao, Lingzhou Zhao, San W, Changcun Liu, Lilei Guo, Yan Xing,
|
SPECT imaging and radionuclide therapy of glioma using 131I labeled Buthus martensii Karsch chlorotoxin
|
J Neurooncol
|
2017
|
133(2):287-295.
|
Shihui Wen, Lingzhou Zhao, Qinghua Zhao, Du Li, Changcun Liu, Zhibo Yu, Mingwu Shen, Jean-Pierre Majoral, Serge Mignani,, Xiangyang Shi
|
A promising dual mode SPECT/CT imaging platform based on 99mTc-labeled multifunctional dendrimer-entrapped gold nanoparticles
|
Journal of Materials Chemistry B
|
2017
|
5:3810-3815
|
Lingzhou Zhao, Xiangyang Shi,
|
Dendrimer-based contrast agents for PET imaging
|
Drug Deliv
|
2017
|
24(2):81-93
|
Lingzhou Zhao, Meilin Zhu, Yujie Li, Yan Xing,
|
Radiolabeled dendrimers for nuclear medicine applications
|
Molecules
|
2017
|
22(9):1350
|
Xiaoying Xu, Lingzhou Zhao, Xin Li, Peng Wang,, Xiangyang Shi, Mingwu Shen
|
Targeted tumor SPECT/CT dual mode imaging using multifunctional RGD-modified low generation dendrimer-entrapped gold nanoparticles
|
Biomater Sci
|
2017
|
5(12):2393-2397
|
Na Sun, Lingzhou Zhao, Wenli Qiao, Yan Xing,
|
BmK CT and 125I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2
|
Mol Med Rep
|
2017
|
15(5):2703-2708
|
Yu Luo, Lingzhou Zhao, Xin Li, Jia Yang, Lilei Guo, Guixiang Zhang, Mingwu Shen,, Xiangyang Shi
|
The design of a multifunctional dendrimer-based nanoplatform for targeted dual mode SPECT/MR imaging of tumors
|
Journal of Materials Chemistry B
|
2016
|
4(45):7220-7225
|
Yongxing Zhang, Shihui Wen, Lingzhou Zhao, Du Li, Changcun Liu, Wenbin Jiang, Xiang Gao, Wentao Gu, Nan Ma,, Xiangyang Shi, Qinghua Zhao,
|
Ultrastable polyethyleneimine-stabilized gold nanoparticles modified with polyethylene glycol for blood pool, lymph node and tumor CT imaging
|
Nanoscale
|
2016
|
8(10):5567-5577
|
Yongjun Cheng, Jingyi Zhu, Lingzhou Zhao, Zhijuan Xiong, Yueqin Tang, Changcun Liu, Lilei Guo, Wenli Qiao, Xiangyang Shi,
|
131I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas
|
Nanomedicine (Lond)
|
2016
|
11(10):1253-1266
|
Lingzhou Zhao,Xiangyang Shi,
|
Chlorotoxin-Conjugated Nanoparticles for Targeted Imaging and Therapy
|
Current Topics in Medicinal Chemistry
|
2015
|
15(13),1196-1208
|
Jingyi Zhu,Lingzhou Zhao,Yongjun Chen,Zhijuan Xiong,Yueqin Tang,Mingwu Shen,,Xiangyang Shi
|
Radionuclide (131)I-labeled multifunctional dendrimers for targeted SPECT imaging and radiotherapy of tumors
|
Nanoscale
|
2015
|
7(43):18169-18178
|
Zhou W,,Xing Y,Chen X,Song J
|
Diffuse hepatic amebiasis detected by FDG PET/CT
|
Clin Nucl Med
|
2015
|
40(2):e167-70
|
Taisong Wang,, Yan Xing
|
Uptake of Technetium-99m DTPA in Bone Metastases from Renal Cancer
|
Clinical Nuclear Medcine
|
2015
|
40(10):840-841
|
Sun N,,Qiao W,Wang T
|
Predictive value of interim PET/CT in DLBCL treated with R-CHOP:meta-analysis
|
Biomed Res Int
|
2015
|
ePub Feb 1
|
Lingzhou Zhao, Jingyi Zhu, Yongjun Chen, Zhijuan Xiong, Yueqin Tang, Lilei Guo, Xiangyang Shi,
|
Chlorotoxin-Conjugated Multifunctional Dendrimers Labeled with Radionuclide 131I for Single Photon Emission Computed Tomography Imaging and Radiotherapy of Gliomasl
|
ACS Applied Material & Interfaces
|
2015
|
7(35):19798-19808
|
Qiao WL,, Xing Y, Wang C, Wang TS
|
Predictive value of [18F] fluoro-2-deoxy-D-glucose positron emission tomography for clinical outcome in patients with relapsed/refractory diffuse large B-cell lymphoma prior to and after autologous stem cell transplant.
|
Leuk Lymphoma
|
2014
|
55(2):276-282
|
Xing Y,, Conti PS, Chen K
|
Radiolabeled Nanoparticles for Multimodality Tumor Imaging
|
Theranostics
|
2014
|
2014, 4(3):290-306
|
Sun Y,, Qiao W, Xing Y, Chen X, Song J
|
Prognostic significance of interim 18F-FDG PET/CT SUV reduction associated with Ki67 in patients with diffuse large B-cell lymphoma
|
Nuclear Science and Techniques
|
2014
|
25(2):020304-1-7
|
宋建华,,邢岩,陈香,汪太松,刘长存
|
18F-FDG PET/CT对原发不明颈部淋巴结转移癌患者原发灶检出的价值
|
中华核医学与分子影像杂志
|
2013
|
33(6):417-420
|
陈香,,宋建华,汪太松,刘长存
|
18F-FDG PET/CT在探测卵巢癌术后复发及转移中的价值
|
中国医学计算机成像杂志
|
2013
|
19(4):376-380
|
Yin H,, Du L
|
Incidental finding of the nutcracker phenomenon detected by 18F-FDG PET/CT
|
Clin Nucl Med
|
2013
|
38(3):212-214
|
乔文礼,,王椿,汪太松,邢岩
|
自体干细胞移植前后18F-FDG PET显像评价非霍奇金淋巴瘤预后的价值
|
世界临床药物
|
2013
|
34(5):275-279
|
孙娜,,乔文礼,邢岩,宋建华,汪太松,刘长存
|
18F-FDG PET/CT在子宫内膜癌诊断和随访中的临床价值
|
中国医学计算机成像杂志
|
2013
|
19(3):278-281
|
孙娜,,乔文礼,赵凌舟
|
125I-BmK CT对胶质瘤细胞侵袭的影响
|
核技术
|
2013
|
36(8):080301-1-4
|
陆燕婷,,汪太松,程斌
|
393例孕妇促甲状腺激素及甲状腺过氧化物酶抗体筛查结果分析
|
标记免疫分析与临床
|
2013
|
20(1):19-22
|
宋建华,,陈香,邢岩
|
18F-FDG PET/CT对肾脏肿瘤的诊断价值
|
中华核医学与分子影像杂志
|
2013
|
33(3):184-187
|
Xing Y,,Song JH,Chen X,Qiao WL.
|
Preoperative detecting metastases of cervical cancer in pelvic and para-aortic lymph nodes: comparison of integrated 18F-FDG PET/CT with or without contrast enhancement.
|
Nuclear Science and Techniques
|
2012
|
23(5):305-311
|
汪太松,,邢岩.
|
99Tcm-MIBI SPECT/CT双时相显像对原发性甲状旁腺功能亢进症的诊断价值
|
中国医学影像学杂志
|
2012
|
20(11):855-857
|
王甜甜,,邢岩,陈香,宋建华,乔文礼.
|
18F-FDG PET/CT显像评价非小细胞肺癌放化疗疗效及复发预测
|
中国医学计算机成像杂志
|
2012
|
18(1):58-62
|
孙一文,,乔文礼,陈香,邢岩,宋建华.
|
化疗前及中期PET/CT标准摄取值对淋巴瘤的预后价值.
|
中国医学计算机成像杂志
|
2012
|
18(4):355-359.
|
Xing Y,, Wang T
|
A case of paranasal sinuses osteoma detected on bone SPECT/CT
|
Clin Nucl Med
|
2011
|
36(3):224-226
|
郭慧敏,,宋建华,乔文礼,刘长存,陈香,邢岩,汪太松
|
18F-FDG PET/CT显像对子宫颈癌的初诊及随访监测价值
|
肿瘤
|
2011
|
31(3):250-254
|
乔文礼,,邵晓霞,张志勇,刘兴峰,汪太松,金文雅,姚玉平
|
131I-BmK CT的制备及其在胶质瘤荷瘤大鼠体内分布与显像研究
|
核技术
|
2011
|
34(3):213-216
|
宋建华,, 陈香, 邢岩, 汪太松, 乔文礼
|
多发性骨髓瘤的18F-FDG PET/CT鉴别诊断及疗效评估价值
|
中国医学计算机成像杂志
|
2011
|
17(1):70-74
|
汪太松,
|
肺癌患者肋骨病变的SPECT/CT影像分析.
|
中国医学影像技术
|
2011
|
27(12):2511-2514
|
Chen X,, Song JH, Xing Y, Wang TS, Qiao WL.
|
Atypical adenomatous hyperplasia in the liver detected by F-18 FDG PET/CT.
|
Clin Nucl Med
|
2010
|
35(8):622-624
|
, Qiao WL, Zhang YN, Shao XX
|
Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent
|
Cancer Biotherapy & Radiopharmaceuticals
|
2010
|
25(3):353-359
|
Qiao WL,, Wang C, Wang TS, Xing Y.
|
Predictive value of 18F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin’s lymphoma prior to and after autologous stem cell transplantation.
|
Hematology
|
2010
|
15(1):21-27
|
, Xing Y, Zhou Q, Jin WY, Wynn W, Howard SB.
|
Can Forearm Bone Mineral Density be Measured With DXA in the Supine Position? A Study in Chinese Population.
|
Cancer J Clin Densitom
|
2010
|
13(2):147-150
|
邢岩,, 汪太松, 乔文礼, 车文军
|
血清CA15-3水平及其倍增时间对18F-FDG SPECT/CT检测乳腺癌复发和转移的影响
|
中华肿瘤防治杂志
|
2010
|
17(2):134-137
|
Chen X,, Song JH, Xing Y, Wang TS, Qiao WL.
|
Dual time point FDG PET imaging in evaluating pulmonary nodules with low FDG avidity
|
Nuclear Science and Techniques
|
2010
|
21(5):257-261
|
刘长存,, 宋建华, 陈香, 邢岩, 汪太松
|
18F-FDG PET/CT联合腹部增强CT对诊断胰腺癌及评估肿瘤可切除性的临床应用
|
中华核医学杂志
|
2010
|
30(2):101-105
|
邢岩,, 汪太松, 乔文礼, 车文军
|
18F-FDG SPECT-CT显像在乳腺癌肿瘤标志物升高患者复发和转移诊断中的价值
|
中华肿瘤杂志
|
2009
|
31(2):129-133
|
张玉娜,,乔文礼,汪太松.
|
18F-FDG符合线路显像探测不明原因发热病灶的临床价值
|
中华核医学杂志
|
2009
|
29(2):135-137
|
宋建华,, 陈香, 邢岩, 汪太松.
|
18F-FDG PET-CT对结直肠癌原发灶检出的临床评价
|
中华胃肠外科杂志
|
2009
|
12(2):174-177
|
乔文礼,,王椿,汪太松,邢岩.
|
自体干细胞移植前后18F-FDG符合线路显像对非霍奇金淋巴瘤预后的评估价值
|
中华核医学杂志
|
2009
|
29(4):246-249
|
Xing Y,, Chen X, Song JH
|
Elevated FDG uptake in right middle segmental bronchus impacted with foreign body
|
Clin Nucl Med
|
2009
|
34(4):241-242
|
, Qiao WL, Wang C, Wang TS, Xing Y.
|
Therapeutic evaluation and prognostic value of interim hybrid PET/CT with 18F-FDG after three to four cycles of chemotherapy in non-Hodgkin’s lymphoma.
|
Hematology
|
2007
|
12(5):423-430
|
|